To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Star Trek Tricorder revisited: Toward a genre of medical scanners
06-01-2012: A hand-held scanner, reminiscent of the fictional Star Trek medical Tricorder, images blood vessels through the skin and projects a map onto the skin showing nurses exactly where to insert a needle. A pocket-sized device checks blood sugar levels through the skin of people with diabetes — no pinprick or blood sample needed. Those innovations are among a new genre of medical imaging technology that's giving doctors and scientists noninvasive views into the body to diagnose and study diseases. A report on the topic appears in Chemical & Engineering News.
In the article, Aaron Alexander Rowe focuses on new optical techniques that use laser beams or so-called near-infrared light to peer painlessly below the skin and through muscle and bone to see body structures. Near-infrared light, just beyond the range visible to the human eye, penetrates several inches into the human body. Two devices described in the article project a near-infrared beam into the skull. The light passes through brain tissue and blood vessels, and then scatters back out, where detectors analyze it in ways that promise to reveal whether patients are bleeding from a stroke or have other disorders.
The article explains that some of the new light-based medical diagnostic tools — the blood vessel mapper, for instance — already are in use in hospitals and clinics. Others are in various stages of pre-clinical development, including devices intended to spot skin cancer, monitor how breast cancer is responding to treatments and produce 3-D images of blockages in blood vessels.
- 1Panspecific antibodies: Novimmune successful in multiple specificities
- 2Rosetta Resolver® Gene Expression Data Analysis System licensed by Aventis Pharmaceuticals, Inc.
- 3Fresenius to acquire US drug-maker APP Pharmaceuticals in US$3.7 billion deal
- 4Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
- 5Merck KGaA Acquires Bioscience Company in India
- 6Pharma’s New Hero: Supergenerics Save Money and Improve Drugs
- 7New marine compound derived from the sea slug against lung cancer and melanoma
- 8Takara Bio to Acquire Clontech Unit of BD Biosciences
- 9Bayer’s Novel Anticoagulant Xarelto now also Approved in the EU
- 10Dr. August Wolff Arzneimittel GmbH & Co. KG and Mercachem B.V. start two drug development collaborations
- Meth users face substantially higher risk for getting Parkinson's disease
- Do caffeine's effects differ with or without sugar?
- Vetter Development Service Chicago is now ready for realizing clinical syringe projects
- A control knob for fat?
- Collaboration between Janssen and USAID to Expand Access to Anti-Multidrug-Resistant Tuberculosis Compound